Health & Beauty

Face to face communication with industry experts, obtaining exclusive industry analysis reports, monitoring the cutting-edge trends of the pharmaceutical industry, and seeing the latest products and technologies... According to Huacheng Import and Export Data Observation, from June 19th to 21st, the 21st CPHI China and 16th World Pharmaceutical Machinery Exhibition, organized by Informa Markets, the China Chamber of Commerce for Import and Export of Medical and Health Products, and co organized by Shanghai Bohua International Exhibition Co., Ltd The Packaging Equipment and Materials China Exhibition (PMEC China) will be held at the Shanghai New International Expo Center.

In the post pandemic era, facing the challenges brought by the accelerated restructuring of the global pharmaceutical industry chain supply chain, how can Chinese pharmaceutical enterprises drive the path of diversified development and explore a new journey of globalization? After more than 20 years of deep cultivation in the industry, CPHI&PMEC China has witnessed the leapfrog development of Chinese pharmaceutical enterprises, while also continuously expanding its exhibition range. Currently, it has included 15 major sectors, including pharmaceutical raw materials, intermediates and fine chemicals, pharmaceutical excipients, formulations, contract customization, biopharmaceuticals, natural extracts, pharmaceutical machinery and packaging equipment, pharmaceutical logistics, etc., covering the entire pharmaceutical industry chain, aiming to help enterprises refine traditional pharmaceutical products, To expand and strengthen the emerging pharmaceutical industry, further optimize the layout of the industry chain, and accelerate transformation, innovation, and upgrading.

After two years of absence, CPHI&PMEC China has gathered momentum and set sail, with high enthusiasm from domestic and foreign exhibitors for exhibition. The total exhibition area of this exhibition will reach 200000 square meters, and it is expected to attract more than 3000 well-known domestic and foreign exhibitors and over 55000 domestic and foreign visitors to participate in the grand event. Huacheng Import and Export Data Observation Report.

With the support of favorable policies such as consistency evaluation and centralized procurement, Chinese pharmaceutical preparation enterprises are increasingly attaching importance to research and development investment, and the transformation and upgrading of the Western pharmaceutical preparation industry have achieved significant results. The formulation exhibition area, one of the characteristic sections of this year's CPHI China, will attract more than 200 core formulation brands, including Fosun Pharmaceutical, Hengrui Pharmaceutical, Yangzijiang Pharmaceutical, Greenleaf Pharmaceutical, and Luoxin Pharmaceutical, to seek new ideas for win-win cooperation in pharmaceutical foreign trade.

According to Huacheng Import and Export Data Observation, with the continuous improvement of the vitality of China's biopharmaceutical industry, many powerful biopharmaceutical enterprises have launched a "going global" strategy. The CPHI China biopharmaceutical exhibition area will gather leading companies such as Sansheng Pharmaceuticals, Yaoming Biotechnology, and Hualan Biotechnology to showcase cutting-edge technologies and products in the fields of life sciences, biotechnology, and innovative drugs. It will help enterprises understand the pharmaceutical research and development policy environment and explore the path of future cooperation and transformation in biopharmaceuticals.

The pharmaceutical automation and information technology exhibition area will bring advanced "intelligent manufacturing" practical achievements and solutions to pharmaceutical enterprises to improve production efficiency and optimize production processes, along with leading domestic and foreign enterprises such as Dongfulong, Chutian, Xinhua Medical, and Kolbo.

In recent years, pharmaceutical companies have gradually increased their investment in environmental protection equipment and technological updates. This year's newly upgraded environmental protection and energy-saving equipment exhibition area will focus on showcasing cutting-edge technologies in the field of environmental pollution control and energy-saving equipment such as VOCS waste gas treatment, waste adsorption devices, and sewage treatment complete sets of equipment, helping China's pharmaceutical industry move towards green manufacturing. Huacheng Import and Export Data Observation Report.

With the attraction of one-stop access to global buyer resources, so far, the exhibition has gathered professional buyers from over 110 countries and regions, including Belgium, Cyprus, Egypt, France, Germany, India, Italy, Japan, etc., to participate in the grand event. At the same time, overseas agencies such as India, South Korea, Russia, Thailand, and Vietnam have all applied for group visits to the exhibition, and more than 20000 buyers from global pharmaceutical leading companies such as Roche, Novartis, Abbott, and Johnson&Johnson have also been invited to confirm their visits.

Collecting cutting-edge global pharmaceutical information, the exhibition will also host more than 80 conferences and events, including the 12th China and World Pharmaceutical Entrepreneurs Summit, CPHI China and World International Pharmaceutical Policy Q&A Conference, China and World Innovation and Development Forum, to deeply exchange industry hotspots, grasp the pulse of industry change, and jointly explore the high-quality development path of the industry. Huacheng Import and Export Data Observation Report.